Factors influencing pharmacokinetics of 5-fluorouracil in cancer patients: a systematic review of population pharmacokinetic models
European Journal of Clinical Pharmacology · 2026
DOI: 10.1007/s00228-026-04043-5 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Clinical Pharmacology, 2026. Verfasst von Teshini Suthahar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576 104, Karnataka, India. Hauptthemen laut MEDLINE: Fluorouracil, Neoplasms, Models, Biological, Antimetabolites, Antineoplastic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Manipal Academy of Higher Education, Manipal.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Purpose 5-Fluorouracil (5-FU) is a traditional chemotherapeutic agent used in the treatment of multiple cancers. This systematic review aimed to summarize the population pharmacokinetic (PopPK) models for both intravenous and pro-drug formulations in cancer patients and to understand the different covariates that affect the pharmacokinetics of 5-FU. Methods the search included studies published from inception to December 2025 in the English language. The non-linear mixed effects model with parametric approach for 5-FU in cancer patients was set as the inclusion criteria. A total of 186 articles were screened for their titles and abstracts from Scopus, PubMed and EMBASE. Out of which 156 were excluded. Out of the 36 articles reviewed, 21 were found suitable for the review. Most of the studies reported a one-compartmental model. Several covariates, including body surface area (BSA), body weight, cancer type, age, gender, UH2/U ratio, serum albumin, creatinine clearance, alkaline phosphatase, total bilirubin, and skeletal muscle index (SMI), influence the pharmacokinetic parameters, including clearance and volume of distribution. Results skeletal muscle index (SMI), body weight, sex, and BSA were the primary covariates influencing the pharmacokinetics of 5-FU. Among the covariates consistently reported as significant, sex was an important determinant of clearance, with males exhibiting higher clearance than females. Increases in body weight and skeletal muscle index were associated with increased clearance, while volume of distribution decreased with lower body surface area. Alkaline phosphatase was reported to have a negative effect on clearance. The substantial interindividual variability observed across studies likely contributes to heterogeneity in reported covariate effects and underscores the need for individualized dosing approaches for 5-FU. Conclusion body weight and sex reported to show clinical significance. This necessitates the need for consideration of these covariates in dosing adjustment. This review summarizes covariates influencing the pharmacokinetics of 5-FU, and reports those identified as significant based on forest plot analysis. This study helps the researchers to perform predictive performance of the reported PopPK models, supporting future model-informed precision dosing strategies for 5-FU-based therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576 104, Karnataka, India.
- Department of Clinical Pharmacology, TN Medical College & BYL Nair Hospital, Dr. AL Nair Road, Mumbai Central, Mumbai, 400 008, India.
- Department of Health Technology and Informatics, Prasanna School of Public Health , Manipal Academy of Higher Education, Manipal, 576 104, Karnataka, India.
- Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Mumbai, India.
- Centre for Pharmacometrics, Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576 104, Karnataka, India.
- Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576 104, Karnataka, India. msv.rajan@manipal.edu.
Förderung
- Manipal Academy of Higher Education, Manipal
Zitieren
APA
Suthahar, T., Veerabhadrappa, J., Munshi, R., Anbu Raj, E., Gota, V., Ivaturi, V., & Mallayasamy, S. (2026). Factors influencing pharmacokinetics of 5-fluorouracil in cancer patients: a systematic review of population pharmacokinetic models. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-026-04043-5
Vancouver
Suthahar T, Veerabhadrappa J, Munshi R, Anbu Raj E, Gota V, Ivaturi V, et al. Factors influencing pharmacokinetics of 5-fluorouracil in cancer patients: a systematic review of population pharmacokinetic models. European Journal of Clinical Pharmacology. 2026. doi:10.1007/s00228-026-04043-5
BibTeX
@article{Suthahar2026,
author = {Suthahar, Teshini and Veerabhadrappa, Jayashree and Munshi, Renuka and Anbu Raj, Elstin and Gota, Vikram and Ivaturi, Vijay and Mallayasamy, Surulivelrajan},
title = {Factors influencing pharmacokinetics of 5-fluorouracil in cancer patients: a systematic review of population pharmacokinetic models},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1007/s00228-026-04043-5}
}
EUVIMED